Walgreens expands Theranos offering to Phoenix market
PHOENIX — Theranos and Walgreens on Wednesday opened new Theranos Wellness Centers located at Walgreens stores in the Phoenix metropolitan area. This marks the next step in Theranos and Walgreens planned national rollout of Theranos Wellness Centers, and the first expansion of the new laboratory services outside of California.
“As we work to bring Theranos’ lab testing services to more of our stores and communities nationwide, we’re excited that Phoenix area residents will be among the first to have this service available in the communities where they live and work,” Kermit Crawford, Walgreens president of pharmacy, health and wellness, said. “Working with Theranos, we’re proud to offer a differentiated patient experience through this latest innovation in health care technology. It’s another way in which we’re providing comprehensive care as part of our mission to transform community pharmacy.”
“Walgreens and Theranos’ partnership can have a real impact on the health and wellbeing of the people of Phoenix,” Phoenix Mayor Greg Stanton said. “I’m proud that Phoenix was chosen for the first broad implementation of a revolutionary lab testing program that makes diagnosis of illnesses fast, inexpensive and convenient. It reflects the success of our decade long investment in the bioscience and health care industries.”
“For the past 10 years, Theranos has worked relentlessly to help make actionable information accessible to individuals and their physicians at the time it matters most. Our goal to bring high quality, affordable lab testing within 5-miles of every home in Phoenix begins today,” Elizabeth Holmes, CEO of Theranos said. “By making it possible to run laboratory tests from a tiny sample, children, elderly and those with chronic conditions or a fear of needles will now be able to partake in a new experience."
The new Theranos Wellness Centers will provide Phoenix area consumers with access to less invasive and more affordable clinician-directed lab testing from a blood sample as small as a few drops — 1/1,000 the size of a typical blood draw. The micro-samples, collected by certified phlebotomists or trained Walgreens technicians, are taken from either a tiny finger stick or traditional methods, eliminating the need for large needles and numerous vials of blood typically required for diagnostic lab testing.
The available tests include a broad spectrum of typical lab requests, including complete blood count, fibrinogen (which tests for heart disease) and hemoglobin A1C (blood sugar control).
Theranos test results can be made available to physicians in a matter of hours, enabling fast diagnoses. Tests are low cost — always 50% of Medicare reimbursement rates or less — and are reimbursed by major insurance carriers, Medicare and Medicaid.
ADA names Walgreens National Strategic Partner
ALEXANDRIA, Va. — The American Diabetes Association on Tuesday announced that Walgreens has been named a National Strategic Partner of the American Diabetes Association, in recognition of its commitment to support the mission and the association’s movement to Stop Diabetes.
The relationship kicks off this November during American Diabetes Month as Walgreens will be conducting a pin pad donation campaign when a debit or credit card is used for payment. In addition, Walgreens will be in seven cities across the country participating in the Association’s educational event — America Diabetes Association Expo. They also will raise critical awareness about American Diabetes Association Alert Day and encourage their customers to take the Diabetes Risk Test to find out if they are at risk for type 2 diabetes.
Walgreens also will be promoting the importance of physical activity by participating in Step Out: Walk to Stop Diabetes events across the country.
"Through its support of the American Diabetes Association, Walgreens is helping to further our movement to Stop Diabetes and plays an integral role in the advancement of our mission," stated Larry Hausner, CEO, American Diabetes Association. "Education and awareness efforts are critical for those who are at risk for type 2 diabetes, as it helps to enhance the importance of leading a healthier lifestyle."
"We are honored to be recognized as a National Strategic Partner of the American Diabetes Association and we are committed to helping people get, stay and live well by raising awareness among our customers about the prevention and detection of type 2 diabetes," commented Kermit Crawford, president of pharmacy, health and wellness, Walgreens. "We are excited about the efforts and activities we have planned for next year with the [ADA] to help raise critical funds in support of their mission, and help educate our consumers about knowing their risk for diabetes and taking steps to prevent and manage their disease."
Waters Corp. recognizes Md. pharmacy school’s mass spectrometry center as ‘center of innovation’
MILFORD, Mass. — Laboratory sciences company Waters Corp. has recognized the University of Maryland School of Pharmacy’s Department of Pharmaceutical Sciences’ mass spectrometry facility as the first to receive its Waters Centers of Innovation honors, the company announced at a ceremony Tuesday.
As part of the Centers of Innovation program, the school will receive priority access to new technologies, opportunities to influence the development of next-generation research instruments, shared opportunities for collaboration with Waters and priority applications support and funding assistance. Waters honored the school for its interdisciplinary research using mass spectrometry to discover new and improved drugs to treat cancer, diabetes and infections diseases.
"Today’s ceremony is a testament to the achievements of this school," University of Maryland, Baltimore president Jay Perman said. "Our new mass spectrometry facility is the largest, most well-equipped and well-staffed facility of its kind in the Mid-Atlantic region, and it will enable us to shorten the time it takes to translate research findings into new diagnostics, therapeutics and preventive procedures that will help patients."